Literature DB >> 20401522

Phase separation of an IgG1 antibody solution under a low ionic strength condition.

Hirotaka Nishi1, Makoto Miyajima, Hiroaki Nakagami, Masanori Noda, Susumu Uchiyama, Kiichi Fukui.   

Abstract

PURPOSE: Phase separation of monoclonal antibody A (MAb A) solution and its relation to protein self-association are studied.
METHODS: A phase diagram of MAb A and its dependence on ionic strength and pH were investigated. The protein self-associations were characterized by dynamic light scattering (DLS), analytical ultracentrifugation analysis (AUC) and viscosity measurement.
RESULTS: MAb A solution with a clear appearance in an isotonic ionic strength condition turned opalescent in a low ionic strength condition, followed by liquid-liquid phase separation (LLPS) into light and heavy phases. The protein concentrations of the two phases were dependent on the ionic strength and pH. The two phases became reversibly miscible when the ionic strength or temperature was increased. DLS and AUC showed that MAb A under a low ionic strength condition self-associates at a protein concentration above the critical concentration of 16.5 mg/mL. The viscosity of the heavy phase was high and dependent on the shear rate. These results indicate that attractive protein-protein interaction in the heavy phase induces LLPS.
CONCLUSIONS: LLPS was induced in MAb A solution in a low ionic strength condition due to reversible protein self-association mediated mainly by attractive electrostatic interaction among the MAb A molecules in the heavy phase.

Mesh:

Substances:

Year:  2010        PMID: 20401522     DOI: 10.1007/s11095-010-0125-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  40 in total

1.  Humanization of the mouse anti-Fas antibody HFE7A and crystal structure of the humanized HFE7A Fab fragment.

Authors:  Hideyuki Haruyama; Shuichiro Ito; Kenji Miyadai; Tohru Takahashi; Reimi Kawaida; Tomoko Takayama; Hiroyuki Hanzawa; Tadashi Hata; Junko Yamaguchi; Hiroko Yoshida-Kato; Kimihisa Ichikawa; Jun Ohsumi; Shin Yonehara; Nobufusa Serizawa
Journal:  Biol Pharm Bull       Date:  2002-12       Impact factor: 2.233

2.  Equilibrium cluster formation in concentrated protein solutions and colloids.

Authors:  Anna Stradner; Helen Sedgwick; Frédéric Cardinaux; Wilson C K Poon; Stefan U Egelhaaf; Peter Schurtenberger
Journal:  Nature       Date:  2004-11-25       Impact factor: 49.962

3.  Characterization of protein aggregation: the case of a therapeutic immunoglobulin.

Authors:  Barthélemy Demeule; M Jayne Lawrence; Alex F Drake; Robert Gurny; Tudor Arvinte
Journal:  Biochim Biophys Acta       Date:  2006-10-27

4.  Quantitation of aggregates in therapeutic proteins using sedimentation velocity analytical ultracentrifugation: practical considerations that affect precision and accuracy.

Authors:  Allen Pekar; Muppalla Sukumar
Journal:  Anal Biochem       Date:  2007-04-27       Impact factor: 3.365

5.  Viscoelastic characterization of high concentration antibody formulations using quartz crystal microbalance with dissipation monitoring.

Authors:  Ankit R Patel; Bruce A Kerwin; Sekhar R Kanapuram
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

6.  Liquid high concentration IgG1 antibody formulations by precipitation.

Authors:  Susanne Matheus; Wolfgang Friess; Daniel Schwartz; Hanns-Christian Mahler
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

Review 7.  Molecular crowding: analysis of effects of high concentrations of inert cosolutes on biochemical equilibria and rates in terms of volume exclusion.

Authors:  A P Minton
Journal:  Methods Enzymol       Date:  1998       Impact factor: 1.600

8.  Selective antibody precipitation using polyelectrolytes: a novel approach to the purification of monoclonal antibodies.

Authors:  Paul McDonald; Corazon Victa; Jayme N Carter-Franklin; Robert Fahrner
Journal:  Biotechnol Bioeng       Date:  2009-03-01       Impact factor: 4.530

9.  Long- and short-range electrostatic interactions affect the rheology of highly concentrated antibody solutions.

Authors:  Ravi Chari; Kavita Jerath; Advait V Badkar; Devendra S Kalonia
Journal:  Pharm Res       Date:  2009-10-01       Impact factor: 4.200

10.  Effects of antibody affinity and antigen valence on molecular forms of immune complexes.

Authors:  Masayuki Oda; Susumu Uchiyama; Masanori Noda; Yoshinori Nishi; Maiko Koga; Kouta Mayanagi; Carol V Robinson; Kiichi Fukui; Yuji Kobayashi; Kosuke Morikawa; Takachika Azuma
Journal:  Mol Immunol       Date:  2009-10-02       Impact factor: 4.407

View more
  24 in total

1.  High-throughput analysis of concentration-dependent antibody self-association.

Authors:  Shantanu V Sule; Muppalla Sukumar; William F Weiss; Anna Marie Marcelino-Cruz; Tyler Sample; Peter M Tessier
Journal:  Biophys J       Date:  2011-10-05       Impact factor: 4.033

2.  Liquid-liquid phase separation of a monoclonal antibody and nonmonotonic influence of Hofmeister anions.

Authors:  Bruce D Mason; Jian Zhang-van Enk; Le Zhang; Richard L Remmele; Jifeng Zhang
Journal:  Biophys J       Date:  2010-12-01       Impact factor: 4.033

3.  Phase transitions in human IgG solutions.

Authors:  Ying Wang; Aleksey Lomakin; Ramil F Latypov; Jacob P Laubach; Teru Hideshima; Paul G Richardson; Nikhil C Munshi; Kenneth C Anderson; George B Benedek
Journal:  J Chem Phys       Date:  2013-09-28       Impact factor: 3.488

4.  Behavior of monoclonal antibodies: relation between the second virial coefficient (B (2)) at low concentrations and aggregation propensity and viscosity at high concentrations.

Authors:  Shuntaro Saito; Jun Hasegawa; Naoki Kobayashi; Naoyuki Kishi; Susumu Uchiyama; Kiichi Fukui
Journal:  Pharm Res       Date:  2011-08-19       Impact factor: 4.200

5.  Phase separation in solutions of monoclonal antibodies and the effect of human serum albumin.

Authors:  Ying Wang; Aleksey Lomakin; Ramil F Latypov; George B Benedek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-15       Impact factor: 11.205

6.  Quantitative Correlation between Viscosity of Concentrated MAb Solutions and Particle Size Parameters Obtained from Small-Angle X-ray Scattering.

Authors:  Masakazu Fukuda; Chifumi Moriyama; Tadao Yamazaki; Yoshimi Imaeda; Akiko Koga
Journal:  Pharm Res       Date:  2015-06-16       Impact factor: 4.200

7.  Energetic Dissection of Mab-Specific Reversible Self-Association Reveals Unique Thermodynamic Signatures.

Authors:  Mandi M Hopkins; Arun Parupudi; Jared S Bee; David L Bain
Journal:  Pharm Res       Date:  2021-02-18       Impact factor: 4.200

8.  Resolving self-association of a therapeutic antibody by formulation optimization and molecular approaches.

Authors:  Paul Casaz; Elisabeth Boucher; Rachel Wollacott; Brian G Pierce; Rachel Rivera; Maja Sedic; Sadettin Ozturk; William D Thomas; Yang Wang
Journal:  MAbs       Date:  2014       Impact factor: 5.857

9.  Pathological crystallization of human immunoglobulins.

Authors:  Ying Wang; Aleksey Lomakin; Teru Hideshima; Jacob P Laubach; Olutayo Ogun; Paul G Richardson; Nikhil C Munshi; Kenneth C Anderson; George B Benedek
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

10.  Effects of ionic strength and sugars on the aggregation propensity of monoclonal antibodies: influence of colloidal and conformational stabilities.

Authors:  Shuntaro Saito; Jun Hasegawa; Naoki Kobayashi; Toshiaki Tomitsuka; Susumu Uchiyama; Kiichi Fukui
Journal:  Pharm Res       Date:  2013-01-15       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.